Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
The flu is estimated to cause 400,000 respiratory deaths each year on average across the world. These deaths come from pneumonia and other respiratory symptoms caused by the flu. People also die from other complications of the flu – such as a stroke or heart attack – but global estimates have not been made of their death toll. The Spanish flu caused the largest influenza pandemic in history. Yet, data on the flu is limited. With better testing, countries could improve their response to flu epidemics. It could help to rapidly identify new strains, detect epidemics early, and design better-matched vaccines to target flu strains circulating in the population.
this data set contains the vaccine coverage around the world from 2018 to 2022.
Facebook
TwitterThis dataset is a per-state amalgamation of demographic, public health and other relevant predictors for COVID-19.
Used positive, death and totalTestResults from the API for, respectively, Infected, Deaths and Tested in this dataset.
Please read the documentation of the API for more context on those columns
Density is people per meter squared https://worldpopulationreview.com/states/
https://worldpopulationreview.com/states/gdp-by-state/
https://worldpopulationreview.com/states/per-capita-income-by-state/
https://en.wikipedia.org/wiki/List_of_U.S._states_by_Gini_coefficient
Rates from Feb 2020 and are percentage of labor force
https://www.bls.gov/web/laus/laumstrk.htm
Ratio is Male / Female
https://www.kff.org/other/state-indicator/distribution-by-gender/
https://worldpopulationreview.com/states/smoking-rates-by-state/
Death rate per 100,000 people
https://www.cdc.gov/nchs/pressroom/sosmap/flu_pneumonia_mortality/flu_pneumonia.htm
Death rate per 100,000 people
https://www.cdc.gov/nchs/pressroom/sosmap/lung_disease_mortality/lung_disease.htm
https://www.kff.org/other/state-indicator/total-active-physicians/
https://www.kff.org/other/state-indicator/total-hospitals
Includes spending for all health care services and products by state of residence. Hospital spending is included and reflects the total net revenue. Costs such as insurance, administration, research, and construction expenses are not included.
https://www.kff.org/other/state-indicator/avg-annual-growth-per-capita/
Pollution: Average exposure of the general public to particulate matter of 2.5 microns or less (PM2.5) measured in micrograms per cubic meter (3-year estimate)
https://www.americashealthrankings.org/explore/annual/measure/air/state/ALL
For each state, number of medium and large airports https://en.wikipedia.org/wiki/List_of_the_busiest_airports_in_the_United_States
Note that FL was incorrect in the table, but is corrected in the Hottest States paragraph
https://worldpopulationreview.com/states/average-temperatures-by-state/
District of Columbia temperature computed as the average of Maryland and Virginia
Urbanization as a percentage of the population https://www.icip.iastate.edu/tables/population/urban-pct-states
https://www.kff.org/other/state-indicator/distribution-by-age/
Schools that haven't closed are marked NaN https://www.edweek.org/ew/section/multimedia/map-coronavirus-and-school-closures.html
Note that some datasets above did not contain data for District of Columbia, this missing data was found via Google searches manually entered.
Facebook
Twitterhttps://www.usa.gov/government-workshttps://www.usa.gov/government-works
This dataset represents preliminary estimates of cumulative U.S. COVID-19 disease burden for the 2024-2025 period, including illnesses, outpatient visits, hospitalizations, and deaths. The weekly COVID-19-associated burden estimates are preliminary and based on continuously collected surveillance data from patients hospitalized with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. The data come from the Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET), a surveillance platform that captures data from hospitals that serve about 10% of the U.S. population. Each week CDC estimates a range (i.e., lower estimate and an upper estimate) of COVID-19 -associated burden that have occurred since October 1, 2024.
Note: Data are preliminary and subject to change as more data become available. Rates for recent COVID-19-associated hospital admissions are subject to reporting delays; as new data are received each week, previous rates are updated accordingly.
References
Facebook
Twitterhttp://opendatacommons.org/licenses/dbcl/1.0/http://opendatacommons.org/licenses/dbcl/1.0/
Why did I create this dataset? This is my first time creating a notebook in Kaggle and I am interested in learning more about COVID-19 and how different countries are affected by it and why. It might be useful to compare different metrics between different countries. And I also wanted to participate in a challenge, and I've decided to join the COVID-19 datasets challenge. While looking through the projects, I noticed https://www.kaggle.com/koryto/countryinfo and it inspired me to start this project.
My approach is to scour the Internet and Kaggle looking for country data that can potentially have an impact on how the COVID-19 pandemic spreads. In the end, I ended up with the following for each country:
See covid19_data - data_sources.csv for data source details.
Notebook: https://www.kaggle.com/bitsnpieces/covid19-data
Since I did not personally collect each datapoint, and because each datasource is different with different objectives, collected at different times, measured in different ways, any inferences from this dataset will need further investigation.
I want to acknowledge the authors of the datasets that made their data publicly available which has made this project possible. Banner image is by Brian.
I hope that the community finds this dataset useful. Feel free to recommend other datasets that you think will be useful / relevant! Thanks for looking.
Facebook
TwitterRank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.
Facebook
Twitterhttps://www.usa.gov/government-workshttps://www.usa.gov/government-works
This dataset represents preliminary estimates of cumulative U.S. RSV –associated disease burden estimates for the 2024-2025 season, including outpatient visits, hospitalizations, and deaths. Real-time estimates are preliminary and based on continuously collected surveillance data from patients hospitalized with laboratory-confirmed respiratory syncytial virus (RSV) infections. The data come from the Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET), a surveillance platform that captures data from hospitals that serve about 8% of the U.S. population. Each week CDC estimates a range (i.e., lower estimate and an upper estimate) of RSV-associated disease burden estimates that have occurred since October 1, 2024.
Note: Data are preliminary and subject to change as more data become available. Rates for recent RSV-associated hospital admissions are subject to reporting delays; as new data are received each week, previous rates are updated accordingly.
Note: Preliminary burden estimates are not inclusive of data from all RSV-NET sites. Due to model limitations, sites with small sample sizes can impact estimates in unpredictable ways and are excluded for the benefit of model stability. CDC is working to address model limitations and include data from all sites in final burden estimates.
References
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture.Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013–2018) at a pediatric referral hospital. Patients with influenza were identified from the clinical laboratory database. All hospitalized patients with confirmed SARS-CoV2 infection were followed-up prospectively.Results: A total of 295 patients with influenza and 133 with SARS-CoV2 infection were included. The median age was 3.7 years for influenza and 5.3 years for SARS-CoV2. Comorbidities were frequent in both groups, but they were more common in patients with influenza (96.6 vs. 82.7%, p < 0.001). Fever and cough were the most common clinical manifestations in both groups. Rhinorrhea was present in more than half of children with influenza but was infrequent in those with COVID-19 (53.6 vs. 5.8%, p < 0.001). Overall, 6.4% percent of patients with influenza and 7.5% percent of patients with SARS-CoV2 infection died. In-hospital mortality and the need for mechanical ventilation among symptomatic patients were similar between groups in the multivariate analysis.Conclusions: Influenza and COVID-19 have a similar picture in pediatric patients, which makes diagnostic testing necessary for adequate diagnosis and management. Even though most cases of COVID-19 in children are asymptomatic or mild, the risk of death among hospitalized patients with comorbidities may be substantial, especially among infants.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
The flu is estimated to cause 400,000 respiratory deaths each year on average across the world. These deaths come from pneumonia and other respiratory symptoms caused by the flu. People also die from other complications of the flu – such as a stroke or heart attack – but global estimates have not been made of their death toll. The Spanish flu caused the largest influenza pandemic in history. Yet, data on the flu is limited. With better testing, countries could improve their response to flu epidemics. It could help to rapidly identify new strains, detect epidemics early, and design better-matched vaccines to target flu strains circulating in the population.
this data set contains the vaccine coverage around the world from 2018 to 2022.